Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache
Public ClinicalTrials.gov record NCT02423408. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Proof-of-Concept Phase 2, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-201 for the Treatment of A Single Tension-Type Headache
Study identification
- NCT ID
- NCT02423408
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Tonix Pharmaceuticals, Inc.
- Industry
- Enrollment
- 165 participants
Conditions and interventions
Conditions
Interventions
- TNX-201 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2015
- Primary completion
- Jan 31, 2016
- Completion
- Jan 31, 2016
- Last update posted
- Apr 10, 2017
2015 – 2016
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| James D. Wolfe, MD | San Jose | California | 95117 | — |
| Avail Clinical Research LLC. | DeLand | Florida | 32720 | — |
| Nathan Segall, MD, CPI | Stockbridge | Georgia | 30281 | — |
| Michigan Head-Pain Neurological Institute | Ann Arbor | Michigan | 48104 | — |
| Gary D. Berman, MD | Minneapolis | Minnesota | 55402 | — |
| John Rubino, MD | Raleigh | North Carolina | 27609 | — |
| PMG Research of Winston-Salem, LLC. | Winston-Salem | North Carolina | 27103 | — |
| Rapid Medical Research, Inc. | Cleveland | Ohio | 44122 | — |
| Stephan C. Sharp, MD | Nashville | Tennessee | 37203 | — |
| Duane G. Wombolt, MD | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02423408, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 10, 2017 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02423408 live on ClinicalTrials.gov.